Research Article

Abnormal Levels of Liver Enzymes and Hepatotoxicity in HIV-Positive, TB, and HIV/TB-Coinfected Patients on Treatment in Fako Division, Southwest Region of Cameroon

Table 1

Baseline characteristics of the study population stratified by treatment groups.

VariableSubclassHIV (%)TB (%)TB/HIV (%)Total (%) value

GenderFemale46 (60.5)15 (46.9)07 (41.2)68 (54.4)3.07870.214
Male30 (39.5)17 (53.1)10 (58.8)57 (45.6)

Age (years)<4034 (44.7)22 (68.8)6 (35.3)62 (49.6)6.80510.332
≥4042 (55.3)10 (31.2)11 (64.7)63 (50.4)
Mean age (±SD)

BMIUnderweight04 (5.3)05 (15.6)01 (5.9)10 (8.00)7.44440.11418
Normal40 (52.6)20 (62.5)12 (70.6)72 (57.6)
Overweight32 (42.1)07 (21.9)04 (23.5)43 (34.4)
Mean BMI (±SD)

EducationNFE+primary23 (30.3)10 (31.2)06 (35.3)39 (31.2)7.72850.102046
Secondary41 (53.9)11 (34.4)05 (29.4)57 (45.6)
Tertiary12 (15.8)11 (34.4)06 (35.3)29 (23.2)

Marital statusMarried28 (36.8)11 (34.4)06 (35.3)45 (36.0)0.06370.968
Unmarried48 (63.2)21 (65.6)11 (64.7)80 (64.0)

OccupationSkilled13 (17.1)02 (6.3)03 (17.6)18 (12.8)11.65560.070109
Unskilled54 (71.1)22 (68.8)12 (70.6)88 (72.0)
Student03 (3.9)07 (21.8)2 (11.8)12 (9.60)
Unemployed06 (7.9)01 (3.1)00 (0.00)07 (5.60)

WHO clinical stageStage 000 (0.0)32 (100.0)00 (0.00)32 (25.6)
Stage 118 (23.7)00 (0.00)04 (23.5)22 (17.6)
Stage 239 (51.3)00 (0.00)06 (35.3)45 (36.0)
Stage 319 (25.0)00 (0.00)07 (41.2)26 (20.8)

BCG scarYes44 (57.9)20 (62.5)09 (52.9)73 (58.4)0.43790.80335
No32 (42.1)12 (37.5)08 (47.1)52 (41.6)

LNEYes0 (0.0)0 (0.0)2 (11.8)2 (1.6)
No76 (100.0)32 (100.0)15 (88.2)123 (98.4)

Type of TBPulmonary00 (0.0)27 (84.4)16 (94.1)43 (34.4)
Extrapulmonary00 (0.0)05 (15.6)01 (5.9)06 (4.8)
Negative76 (100)00 (0.0)00 (00.0)76 (60.8)

OIYes31 (40.8)00 (0.0)03 (17.6)34 (27.2)
No45 (59.2)32 (100.0)14 (82.4)91 (72.8)

MalariaYes17 (22.4)12 (37.5)07 (41.2)36 (28.8)3.98420.136
No59 (77.6)20 (62.5)10 (58.8)89 (71.2)
Total

OI = opportunistic infection; NFE = no formal education.